JARED MARSHALL: Open Payments
NPI 1265880918 · MIDDLETOWN, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,901 in 98 payments from 18 companies in 2025. Trend: 2023 $2,059 · 2024 $2,750 · 2025 $1,901
Food & beverage: $1,862Education: $20Travel & lodging: $19
| Company | Payments | Amount |
|---|---|---|
| Alnylam Pharmaceuticals Inc. | 7 | $263 |
| E.R. Squibb & Sons, L.L.C. | 10 | $204 |
| PFIZER INC. | 13 | $185 |
| Amgen Inc. | 7 | $182 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 25 | $178 |
| Bayer Healthcare Pharmaceuticals Inc. | 6 | $142 |
| Novo Nordisk Inc | 5 | $116 |
| Merck Sharp & Dohme LLC | 5 | $115 |
| Novartis Pharmaceuticals Corporation | 4 | $100 |
| Esperion Therapeutics, Inc. | 4 | $91 |
Products named: REPATHA, JARDIANCE, CAMZYOS, ELIQUIS, Kerendia, LEQVIO, Wegovy, NEXLETOL.
Industry payments across CT — which companies pay providers there.
